There are multiple levers that need to be pulled to allow biosimilars to come to market more broadly in the US, explained Fran Gregory, PharmD, MBA, vice president of emerging therapies, Cardinal Health.
Medically integrated dispensaries could be in violation of the Medicare Physician Self-Referral Law, known as the Stark Law, due to an interpretation of the law released in 2021.